Predictors of Smoking Cessation in a Population of Pregnant Smokers in a National Database from 2004 to 2006 pp. 351-366
Authors: (Anne-Laurence Le Faou, Monique Baha, Nicolas Rodon, Département de Santé Publique, Faculté de Médecine Paris Descartes, Université Paris V, Paris, France, and others)
Abstract: Objectives Pregnant women are one of the target populations of the French tobacco control global policy. By characterizing this population and assessing outcomes of smoking cessation, this study aimed at defining the needs of a special subgroup of smokers. Design A cross sectional analysis was performed on a sample of 699 pregnant women registered on the French ―Consultation De Tabacologie‖ (CDT) national database between 2004 and 2006. Methods Baseline variables concerned sociodemographic details, psychological and medical history, and characteristics of tobacco consumption. The details of the smoking cessation intervention were also examined. Survival analysis and logistic regression models were used to determine predictors of the outcomes. Findings History of depressive episodes was reported by 31.4% (n = 218) of women. One third had high nicotine dependence, according to the Fagerström Test for Nicotine Dependence, and about 40% had never made any attempts to quit smoking. Nicotine replacement therapy was prescribed to 83.0% (n = 567) of the patients and 32.6% (n = 223) received cognitive behavioural therapy. 62.0% (n = 433) of the study sample was lost to follow up, 14.3% (n = 94) women were carbon monoxide-validated quitters. The main predictors of smoking cessation were the intake of anxiolytics prior to the smoking cessation intervention and the use of nicotine patch. Loss to follow-up was highly lowered when psychotropic drugs were prescribed as part of the intervention.